TY - JOUR
T1 - Myeloid sarcoma of the tongue as a first manifestation of acute promyelocytic leukemia: A case report
AU - Ignacio-Cconchoy, Felipe L.
AU - Benites-Zapata, Vicente A.
AU - Yanac-Avila, Rommel L.
AU - Vela-Velàsquez, César T.
N1 - Publisher Copyright:
© 2020 Greater Poland Cancer Centre
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/2/6
Y1 - 2020/2/6
N2 - Introduction: We describe a 35-year-old male patient showing a myeloid sarcoma (MS) of the tongue as the first manifestation of acute promyelocytic leukemia (APL). The MS can appear in all parts of the human body, but it is extremely rare in the tongue. Clinical case: The main symptoms were a pain in the tongue, asthenia, gingivorrhagia, fever. We found a tumor in the tongue, which was irregular in size and located in the posterior region of the right lateral edge of the tongue. The diagnosis of MS was made by the anatomopathological and immunohistochemical study, while the definite diagnosis of APL was confirmed by the molecular test. The treatment of APL was based on the administration of trans-retinoic acid 45 mg/m
2 daily continuously and daunorubicin 60 mg/m
2 every other day for 4 doses, with a favorable therapeutic response to APL and MS. Conclusion: Promyelocytic myeloid cells can infiltrate many organs extramedullary, such as the tongue, and this might precede bone marrow infiltration. The early identification of myeloid sarcoma allows to carry out an early treatment of the APL.
AB - Introduction: We describe a 35-year-old male patient showing a myeloid sarcoma (MS) of the tongue as the first manifestation of acute promyelocytic leukemia (APL). The MS can appear in all parts of the human body, but it is extremely rare in the tongue. Clinical case: The main symptoms were a pain in the tongue, asthenia, gingivorrhagia, fever. We found a tumor in the tongue, which was irregular in size and located in the posterior region of the right lateral edge of the tongue. The diagnosis of MS was made by the anatomopathological and immunohistochemical study, while the definite diagnosis of APL was confirmed by the molecular test. The treatment of APL was based on the administration of trans-retinoic acid 45 mg/m
2 daily continuously and daunorubicin 60 mg/m
2 every other day for 4 doses, with a favorable therapeutic response to APL and MS. Conclusion: Promyelocytic myeloid cells can infiltrate many organs extramedullary, such as the tongue, and this might precede bone marrow infiltration. The early identification of myeloid sarcoma allows to carry out an early treatment of the APL.
KW - Acute promyelocytic leukemia
KW - Myeloid sarcoma
KW - Tongue
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85078135467&origin=inward
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85078135467&origin=inward
UR - http://www.scopus.com/inward/record.url?scp=85078135467&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/c32ea12f-1aad-31e5-b5c3-692cde191455/
U2 - 10.1016/j.rpor.2019.12.026
DO - 10.1016/j.rpor.2019.12.026
M3 - Article
C2 - 32021572
SN - 1507-1367
VL - 25
SP - 174
EP - 177
JO - Reports of Practical Oncology and Radiotherapy
JF - Reports of Practical Oncology and Radiotherapy
IS - 2
ER -